Research and Development

Information for this article came from the Digitial Jounal. The orginal article can be accessed here.

A new malaria drug with the potential to cure the disease and block its transmission, developed by an international group of researchers has progressed to an advanced trial stage.

The new drug, ELQ-300, has been shown to be extremely potent in mice. It belongs to a family of synthetic compounds known as quinolones.

The Oregonian reports on a potential breakthrough for scientists attempt to defeat the malaria parasite’s ability to build a resistance to malarial drugs.

“Researchers at the Portland Veteran Affairs Medical Center report compounds they developed readily kill drug-resistant malaria in animals and in human cells grown in cultures.”

On Wednesday, April 25, World Malaria Day was celebrated on Capitol Hill in a two-part event entitled, “U.S.